Jim Penman proposes partnering with the University of Tokyo to advance epigenetics research through open-source drug protocols and biomarkers. He wants to publish a book for policymakers to pressure governments into funding new labs, betting that Japan's scientific community could launch a dedicated institute with modest seed money.
Chapters
In fact, some of these tests we probably will do overseas. There's other countries that are just as well suited or even better. The Japanese could do that. We'll show them exactly what to do. We'll show them the drugs that we're using because we're not out to make a profit. We say, these are the drugs we're testing, these are the results, this is the epigenetic system we want, these are the pathways in the brain you want to look at, this is all our results. You take it and go for it. Set up an institute at the University of Tokyo and start working on it. It's just a small amount of money. Basically, the idea is to reach enough people with the book that some people in power are going to be thinking, okay, we've tried everything else, it hasn't worked. Here's a fairly small amount money by their terms that has potential to do this. So let's give it a try. Let's just fund some labs. There are lots of brilliant scientists in Japan. Put them into this problem and see what you can do with it. I'm very confident that we can achieve it.